Last Price
0.074
Today's Change
-0.011 (12.94%)
Day's Change
0.072 - 0.086
Trading Volume
19,173,719
Market Cap
8 Million
Shares Outstanding
119 Million
Avg Volume
52,060,954
Avg Price (50 Days)
0.09
Avg Price (200 Days)
0.97
PE Ratio
-0.32
EPS
-0.23
Earnings Announcement
18-Nov-2024
Previous Close
0.09
Open
0.09
Day's Range
0.0723 - 0.0856
Year Range
0.051 - 3.92
Trading Volume
19,248,524
1 Day Change
-13.18%
5 Day Change
-33.93%
1 Month Change
-0.14%
3 Month Change
-35.49%
6 Month Change
-70.61%
Ytd Change
-2.51%
1 Year Change
-97.92%
3 Year Change
-99.26%
5 Year Change
-99.26%
10 Year Change
-99.26%
Max Change
-99.26%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.